1641 related articles for article (PubMed ID: 25585328)
1. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
2. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
3. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
4. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
5. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
[TBL] [Abstract][Full Text] [Related]
7. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
8. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
[TBL] [Abstract][Full Text] [Related]
9. Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.
Ward-Peterson M; Acuña JM; Alkhalifah MK; Nasiri AM; Al-Akeel ES; Alkhaldi TM; Dawari SA; Aldaham SA
Medicine (Baltimore); 2016 Apr; 95(17):e3315. PubMed ID: 27124020
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
11. Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016.
Nobel TB; Asumeng CK; Jasek J; Van Beck KC; Mathur R; Qiao B; Brown JJ
Cancer Med; 2020 Nov; 9(21):8226-8234. PubMed ID: 33006431
[TBL] [Abstract][Full Text] [Related]
12. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
14. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN
Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810
[TBL] [Abstract][Full Text] [Related]
15. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
16. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
17. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
18. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ
Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391
[TBL] [Abstract][Full Text] [Related]
19. Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Li CI; Malone KE; Daling JR
Arch Intern Med; 2003 Jan; 163(1):49-56. PubMed ID: 12523916
[TBL] [Abstract][Full Text] [Related]
20. Does utilization of screening mammography explain racial and ethnic differences in breast cancer?
Smith-Bindman R; Miglioretti DL; Lurie N; Abraham L; Barbash RB; Strzelczyk J; Dignan M; Barlow WE; Beasley CM; Kerlikowske K
Ann Intern Med; 2006 Apr; 144(8):541-53. PubMed ID: 16618951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
